Related references
Note: Only part of the references are listed.Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype
Irmgard Tegeder et al.
EUROPEAN JOURNAL OF PAIN (2008)
Individual differences in pain sensitivity: Genetic and environmental contributions
Christopher S. Nielsen et al.
PAIN (2008)
Principle components analysis of pain thresholds to thermal, electrical, and mechanical stimuli suggests a predominant common source of variance
Till J. Neddermeyer et al.
PAIN (2008)
Genetic mutations that prevent pain:: implications for future pain medication
Bruno Oertel et al.
PHARMACOGENOMICS (2008)
Current evidence for a modulation of nociception by human genetic polymorphisms
Joern Loetsch et al.
PAIN (2007)
Placebo effects on human μ-opioid activity during pain
Tor D. Wager et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms
Joern Loetsch et al.
CLINICAL CHEMISTRY (2007)
Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans
Hyungsuk Kim et al.
MOLECULAR PAIN (2007)
Nitric oxide activates TRP channels by cysteine S-nitrosylation
Takashi Yoshida et al.
NATURE CHEMICAL BIOLOGY (2006)
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
Irmgard Tegeder et al.
NATURE MEDICINE (2006)
Individual differences in endogenous pain modulation as a risk factor for chronic pain
RR Edwards
NEUROLOGY (2005)
Quantitative assessment of experimental pain perception: multiple domains of clinical relevance
RR Edwards et al.
PAIN (2005)
Ethnic differences and responses to pain in healthy young adults
BA Hastie et al.
PAIN MEDICINE (2005)
Ethnic differences in responses to multiple experimental pain stimuli
CM Campbell et al.
PAIN (2005)
Population stratification and spurious allelic association
LR Cardon et al.
LANCET (2003)
Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET)
B Bencherif et al.
PAIN (2002)
Naloxone increases pain induced by topical capsaicin in healthy human volunteers
WS Anderson et al.
PAIN (2002)
The vanilloid receptor: A molecular gateway to the pain pathway
MJ Caterina et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Share Paper
